Spots Global Cancer Trial Database for Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel
Official Title: Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel
Study ID: NCT05776134
Interventions
Study Description
Brief Summary: The goal of this study is to provide access to brexucabtagene autoleucel for patients diagnosed with a disease approved for treatment with brexucabtagene autoleucel, that is otherwise out of specification for commercial release.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
City of Hope, Duarte, California, United States
Colorado Blood Cancer Institute, Denver, Colorado, United States
Winship Cancer Institute, Atlanta, Georgia, United States
Northside Hospital, Atlanta, Georgia, United States
Northwestern Memorial Hospital, Chicago, Illinois, United States
The University of Kansas Medical Center, Westwood, Kansas, United States
University of Maryland Cancer Center, Baltimore, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Dana Farber Cancer Institute - Chestnut Hill, Boston, Massachusetts, United States
University of Michigan, Ann Arbor, Michigan, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University School of Medicine- Siteman Cancer Center, Saint Louis, Missouri, United States
University of Nebraska Medical Center, Omaha, Nebraska, United States
Montefiore Medical Center, Bronx, New York, United States
UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Cleveland Clinic, Cleveland, Ohio, United States
The Ohio State University, Columbus, Ohio, United States
Oregon Health & Science University, Portland, Oregon, United States
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Avera Cancer Institute, Sioux Falls, South Dakota, United States
Sarah Canon Research Institute, Nashville, Tennessee, United States
Houston Methodist Hospital, Houston, Texas, United States
MD Anderson Cancer Center, Houston, Texas, United States
Methodist Healthcare System of San Antonio dba Methodist Hospital, San Antonio, Texas, United States
Virginia Commonwealth University, Richmond, Virginia, United States
Fred Hutchinson Cancer Center, Seattle, Washington, United States
West Virginia University, Morgantown, West Virginia, United States
Contact Details
Name: Kite Study Director
Affiliation: Kite, A Gilead Company
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
